Evotec SE (EVOTF)
OTCMKTS · Delayed Price · Currency is USD
7.28
0.00 (0.00%)
At close: Sep 16, 2025
Evotec SE Market Cap
Evotec SE has a market cap or net worth of $1.31 billion as of September 19, 2025. Its market cap has increased by 12.04% in one year.
Market Cap
1.31B
Enterprise Value
1.44B
Revenue
912.89M
Ranking
n/a
PE Ratio
n/a
Stock Price
$7.28
Market Cap Chart
Since November 11, 1999, Evotec SE's market cap has increased from 4.65M to 1.31B, an increase of 28,025.20%. That is a compound annual growth rate of 24.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 19, 2025 | 1.31B | -13.22% |
| Dec 30, 2024 | 1.51B | -63.78% |
| Dec 29, 2023 | 4.16B | 44.42% |
| Dec 30, 2022 | 2.88B | -65.81% |
| Dec 30, 2021 | 8.43B | 38.57% |
| Dec 30, 2020 | 6.08B | 56.16% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 789.71M |
| Elite Pharmaceuticals | 697.08M |
| Tian'an Technology Group | 609.94M |
| Glass House Brands | 575.59M |
| Northwest Biotherapeutics | 378.51M |
| Nika Pharmaceuticals | 370.64M |
| CytoDyn | 352.05M |
| American Oncology Network | 340.34M |